PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Adherence to American Cancer Society nutrition and physical activity guidelines among cancer survivors

JAMA Oncology

2024-04-18
(Press-News.org) About The Study: In this cross-sectional study using data from the Behavioral Risk Factor Surveillance System for 10,000 cancer survivors, only 4% of cancer survivors adhered to all four American Cancer Society nutrition and physical activity guidelines, with the mean number of guidelines met being 2.0. Improved understanding of guideline adherence and its determinants may guide oncologists and general internists in providing recommendations for their patients who have completed cancer treatments. 

Authors: Kathryn Norman, M.D., of the Beth Israel Deaconess Medical Center in Boston, is the corresponding author. 

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamaoncol.2024.0470)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.0470?guestAccessKey=1e2fa0a7-e366-45a2-94c1-969d3f1c82ab&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041824

 

END


ELSE PRESS RELEASES FROM THIS DATE:

New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies

2024-04-18
ANN ARBOR, Michigan — Researchers at the University of Michigan Rogel Cancer Center have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.   The test, called MyProstateScore2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. In multiple tests using urine and tissue samples from men with prostate cancer, it successfully identified cancers ...

Researchers reduce bias in pathology AI algorithms using foundation models

2024-04-18
Findings of substantial variability in pathology AI models’ performance based on race, insurance type and age group serve as a “call to action” to researchers and regulators to improve medical equity Large foundation models that incorporate a richer level of detail may mitigate disparities between different demographic groups and enhance model accuracy.   Advanced artificial intelligence (AI) systems have shown promise in revolutionalizing the field of pathology through transforming the detection, diagnosis, and treatment of disease; however, the underrepresentation of certain patient populations in pathology ...

Properties of new materials for microchips can now be measured well

Properties of new materials for microchips can now be measured well
2024-04-18
Making ever smaller and more powerful chips requires new ultrathin materials: 2D materials that are only 1 atom thick, or even just a couple of atoms. Think about graphene or ultra-thin silicon membrane for instance. Scientists at TU Delft have taken an important step in application of these materials: they can now measure important thermal properties of ultrathin silicon membranes. A major advantage of their method is that no physical contact needs to be made with the membrane, so pristine properties can ...

Maltreated children are three times more likely to develop substance use disorders in adulthood

2024-04-18
A new study published in the scientific journal Addiction has found that people who are maltreated as children may be three times more likely to be admitted to hospital for alcohol and substance use disorders by the age of 40, compared with those who are not maltreated. The study used data from over 6,000 children born at the Mater Mothers Hospital, Brisbane, Australia between 1981 and 1983.  Ten percent of those children (609 children) had at least one child maltreatment notification (reported or substantiated) up to 15 years of age. Compared with the rest of the children, those 609 ...

Two U professors selected as AAAS fellows

Two U professors selected as AAAS fellows
2024-04-18
University of Utah Health professors Amy Barrios, PhD, and H. Joseph Yost, PhD, have been elected as Fellows of the American Association for the Advancement of Science (AAAS), a lifetime honor that celebrates their excellence in research and commitment to mentoring the next generation of scientists. Yost and Barrios join a distinguished cadre of AAAS Fellows at the U, including Nancy Songer, PhD; Thure Cerling, PhD; Vahe Bandarian, PhD; Eric W. Schmidt, PhD; Jennifer S. Shumaker-Parry, PhD; and Mario Capecchi, PhD. Rachel Hess, MD, associate vice president for research at U of U Health, says, ...

Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science

Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science
2024-04-18
Boston - Kevin Haigis, PhD, Chief Scientific Officer, Dana-Farber Cancer Institute, has been named Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is a distinguished lifetime honor bestowed upon AAAS members by their peers. Haigis is recognized within Biological Sciences for his distinguished contributions to understanding the complex diversity of cellular dysregulation by different variants of RAS mutations and their consequences in pathophysiology and ...

Siblings with unique genetic change help scientists progress drug search for type 1 diabetes

2024-04-18
Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes. Type 1 diabetes (also known as autoimmune diabetes) is a devastating and life-long disease, in which the patient’s immune cells wrongly destroy the insulin producing beta cells in the pancreas. People living with autoimmune diabetes need to test their blood sugar and inject insulin throughout their lives to control their blood sugars and prevent complications. Autoimmune ...

Four MD Anderson researchers elected AAAS Fellows

Four MD Anderson researchers elected AAAS Fellows
2024-04-18
HOUSTON ― In recognition of their significant achievements in the realm of cancer care and research, four researchers at The University of Texas MD Anderson Cancer Center have been elected fellows of the American Association for the Advancement of Science (AAAS). This prestigious distinction stands as one of the highest accolades within the scientific research community. Boyi Gan, Ph.D., Candelaria Gomez-Manzano, M.D., Li Ma, Ph.D., and Sattva Neelapu, M.D., now join this esteemed group of fellows elected by their peers. AAAS’s annual tradition of recognizing leading scientists as fellows dates to 1874. With these newest additions, 68 MD Anderson faculty members ...

Computational biology pioneer Katie Pollard elected as AAAS fellow

Computational biology pioneer Katie Pollard elected as AAAS fellow
2024-04-18
SAN FRANCISCO—April 18, 2024—The American Association for the Advancement of Science (AAAS), one of the world’s largest general scientific societies, has elected Gladstone Senior Investigator Katie Pollard, PhD, into its new class of AAAS Fellows, a lifetime honor within the scientific community. AAAS recognized Pollard for her “distinguished contributions to the field of computational biology and bioinformatics, particularly her discovery of Human Accelerated Regions, and development of ...

New “window-of-opportunity” clinical trials explore cutting-edge treatments for cancers of the liver, head and neck

2024-04-18
April 18, 2024, TORONTO – A new round of clinical trials supported by the Ontario Institute for Cancer Research (OICR) will harness a unique opportunity to test some of the newest treatment strategies for a range of different cancers. OICR has announced two new clinical trials as part of its Window-of-Opportunity (WOO) Network, which brings together Ontario researchers, clinicians and patients to study the biology of newly diagnosed and recurrent tumours. “‘Window-of-opportunity’ clinical trials take advantage of the two-to-eight-week period between the diagnosis of cancer and the surgery to remove the cancer, at ...

LAST 30 PRESS RELEASES:

UC San Diego Health ends negotiations with Tri-City Medical Center Healthcare District

MLB add lifesavers to the chain of survival in New York City

ISU studies explore win-win potential of grass-powered energy production

Study identifies biomarker that could predict whether colon cancer patients benefit from chemotherapy

Children are less likely to have type 1 diabetes if their mother has the condition than if their father is affected

Two shark species documented in Puget Sound for first time by Oregon State researchers

AI method radically speeds predictions of materials’ thermal properties

Study: When allocating scarce resources with AI, randomization can improve fairness

Wencai Liu earns 2024 IUPAP Early Career Scientist Prize in Mathematical Physics

Outsourcing conservation in Africa

Study finds big disparities in stroke services across the US

Media Tip Sheet: Urban Ecology at #ESA2024

Michigan Plasma prize honors University of Illinois professor

Atomic 'GPS' elucidates movement during ultrafast material transitions

UMBC scientists work to build “wind-up” sensors

Researchers receive McKnight award to study the evolution of deadly brain cancer

Heather Dyer selected as the 2024 ESA Regional Policy Award Winner

New study disputes Hunga Tonga volcano’s role in 2023-24 global warm-up

Climate is most important factor in where mammals choose to live, study finds

New study highlights global disparities in activity limitations and assistive device use

Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD

Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery

Insilico Medicine introduces Science42: DORA, the intelligent writing assistant for accelerated research

A deep dive into polyimides for high-frequency wireless telecommunications

Green hydrogen from direct seawater electrolysis- experts warn against hype

Thousands of birds and fish threatened by mining for clean energy transition

Medical and educational indebtedness among health care workers

US state restrictions and excess COVID-19 pandemic deaths

Posttraumatic stress disorder among adults in communities with mass violence incidents

New understanding of fly behavior has potential application in robotics, public safety

[Press-News.org] Adherence to American Cancer Society nutrition and physical activity guidelines among cancer survivors
JAMA Oncology